Anixa Biosciences, Inc. (ANIX): Price and Financial Metrics

Anixa Biosciences, Inc. (ANIX): $2.49

0.01 (+0.40%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

F

ANIX Price/Volume Stats

Current price $2.49 52-week high $5.13
Prev. close $2.48 52-week low $2.40
Day low $2.47 Volume 26,108
Day high $2.50 Avg. volume 129,830
50-day MA $3.04 Dividend yield N/A
200-day MA $3.50 Market Cap 79.43M

ANIX Stock Price Chart Interactive Chart >


Anixa Biosciences, Inc. (ANIX) Company Bio


Anixa Biosciences, Inc., a biotechnology company, develops diagnostics and therapeutics to diagnose, treat, and prevent cancer. The company is developing the Cchek platform, a series of non-invasive blood tests for the early detection of cancer, which is based on the body's immune response to the presence of a malignancy. It is also developing a vaccine against triple negative breast cancer; and chimeric endocrine receptor T-cell technology focused on treating ovarian cancer. Anixa Biosciences, Inc. has a collaboration with Urology San Antonio, P.A. and Idaho Urologic Institute, PA for the development of Cchek, a liquid biopsy technology; and with OntoChem GmbH to develop novel Covid-19 therapeutics. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was founded in 1982 and is based in San Jose, California.


ANIX Latest News Stream


Event/Time News Detail
Loading, please wait...

ANIX Latest Social Stream


Loading social stream, please wait...

View Full ANIX Social Stream

Latest ANIX News From Around the Web

Below are the latest news stories about ANIXA BIOSCIENCES INC that investors may wish to consider to help them evaluate ANIX as an investment opportunity.

Anixa Biosciences to Present at Biotech Showcase 2024

Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a clinical-stage biotechnology company focused on the treatment and prevention of cancer, today announced that it will present an overview of its business and provide updates on its clinical programs at Biotech Showcase, taking place January 8-10, 2024 in San Francisco, California in parallel to the 42nd Annual J.P. Morgan Healthcare Conference ("JPM Week 2024").

Yahoo | December 14, 2023

3 Biotech Stocks to Turn $5,000 Into $1 Million: December 2023

Some of the most explosive opportunities can be found in biotech stocks.

Ian Cooper on InvestorPlace | December 11, 2023

Anixa Biosciences and Cleveland Clinic Present Positive New Data from Phase 1 Study of Breast Cancer Vaccine

Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced new and updated positive results from the Phase 1 clinical trial of its breast cancer vaccine. The trial is being conducted in collaboration with Cleveland Clinic with funding by a grant from the U.S. Department of Defense.

Yahoo | December 6, 2023

Anixa Biosciences to Host Conference Call This Evening to Discuss Positive New Data from Ongoing Phase 1 Study of Breast Cancer Vaccine

Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a clinical-stage biotechnology company focused on the treatment and prevention of cancer, will publicly release new data this evening from the ongoing Phase 1 clinical trial of its breast cancer vaccine, which was presented for the first time today at the 2023 San Antonio Breast Cancer Symposium ("SABCS"). All interested parties are invited to join an upcoming conference call today at 6:30 pm ET to discuss the data.

Yahoo | December 6, 2023

Anixa Biosciences Announces European Patent on Ovarian Cancer Vaccine Technology

Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that its partner, Cleveland Clinic, has received an "Intention to Grant" notice from the European Patent Office ("EPO") for the patent application titled "Ovarian Cancer Vaccines."

Yahoo | November 27, 2023

Read More 'ANIX' Stories Here

ANIX Price Returns

1-mo -16.16%
3-mo -29.06%
6-mo -23.85%
1-year -18.63%
3-year N/A
5-year -40.29%
YTD -35.82%
2023 -8.71%
2022 43.10%
2021 -3.26%
2020 -6.40%
2019 -16.75%

Continue Researching ANIX

Here are a few links from around the web to help you further your research on Anixa Biosciences Inc's stock as an investment opportunity:

Anixa Biosciences Inc (ANIX) Stock Price | Nasdaq
Anixa Biosciences Inc (ANIX) Stock Quote, History and News - Yahoo Finance
Anixa Biosciences Inc (ANIX) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!